Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Update of the stroke therapy academic industry roundtable preclinical recommendations.

Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH; STAIR Group.

Stroke. 2009 Jun;40(6):2244-50. doi: 10.1161/STROKEAHA.108.541128. Epub 2009 Feb 26. Review.

2.

Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.

Fisher M; Stroke Therapy Academic Industry Roundtable.

Stroke. 2003 Jun;34(6):1539-46. Epub 2003 May 15. Review.

3.

Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.

Savitz SI, Fisher M.

Ann Neurol. 2007 May;61(5):396-402. Review.

PMID:
17420989
5.
6.

Preclinical stroke research--advantages and disadvantages of the most common rodent models of focal ischaemia.

Macrae IM.

Br J Pharmacol. 2011 Oct;164(4):1062-78. doi: 10.1111/j.1476-5381.2011.01398.x. Review.

7.

Clinical pharmacological issues in the development of acute stroke therapies.

Ford GA.

Br J Pharmacol. 2008 Mar;153 Suppl 1:S112-9. doi: 10.1038/sj.bjp.0707654. Review.

8.

Nonhuman primate models of stroke for translational neuroprotection research.

Cook DJ, Tymianski M.

Neurotherapeutics. 2012 Apr;9(2):371-9. doi: 10.1007/s13311-012-0115-z. Review.

9.

[In vivo exploration of cerebral ischemia: use of neuroprotective agents in animal studies].

Lestage P, Lockhart B, Roger A.

Therapie. 2002 Nov-Dec;57(6):554-63. Review. French.

PMID:
12666263
10.

Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly.

Green AR.

Br J Pharmacol. 2008 Mar;153 Suppl 1:S325-38. Epub 2007 Dec 3. Review.

11.

Perspectives on neuroprotective stroke therapy.

Schäbitz WR, Fisher M.

Biochem Soc Trans. 2006 Dec;34(Pt 6):1271-6. Review.

PMID:
17073800
12.

Neuroprotection for stroke: current status and future perspectives.

Minnerup J, Sutherland BA, Buchan AM, Kleinschnitz C.

Int J Mol Sci. 2012;13(9):11753-72. doi: 10.3390/ijms130911753. Epub 2012 Sep 18. Review.

13.

Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia.

Durukan A, Tatlisumak T.

Pharmacol Biochem Behav. 2007 May;87(1):179-97. Epub 2007 May 4. Review.

PMID:
17521716
14.
15.

Recommendations for standards regarding preclinical neuroprotective and restorative drug development.

Stroke Therapy Academic Industry Roundtable (STAIR).

Stroke. 1999 Dec;30(12):2752-8. Review.

16.

Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke.

Feuerstein GZ, Zaleska MM, Krams M, Wang X, Day M, Rutkowski JL, Finklestein SP, Pangalos MN, Poole M, Stiles GL, Ruffolo RR, Walsh FL.

J Cereb Blood Flow Metab. 2008 Jan;28(1):217-9. Epub 2007 Jun 20. Review.

17.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

Can J Cardiol. 2009 May;25(5):287-98. Review.

18.

Developing practice recommendations for endovascular revascularization for acute ischemic stroke.

Lazzaro MA, Novakovic RL, Alexandrov AV, Darkhabani Z, Edgell RC, English J, Frei D, Jamieson DG, Janardhan V, Janjua N, Janjua RM, Katzan I, Khatri P, Kirmani JF, Liebeskind DS, Linfante I, Nguyen TN, Saver JL, Shutter L, Xavier A, Yavagal D, Zaidat OO.

Neurology. 2012 Sep 25;79(13 Suppl 1):S243-55. Review.

19.

Improving outcome after stroke: overcoming the translational roadblock.

Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP, Planas A, Rothwell N, Schwaninger M, Schwab ME, Vivien D, Wieloch T, Dirnagl U.

Cerebrovasc Dis. 2008;25(3):268-78. doi: 10.1159/000118039. Epub 2008 Feb 22. Review.

20.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Khan NA, Hemmelgarn B, Padwal R, Larochelle P, Mahon JL, Lewanczuk RZ, McAlister FA, Rabkin SW, Hill MD, Feldman RD, Schiffrin EL, Campbell NR, Logan AG, Arnold M, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Leiter LA, Ogilvie RI, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Burns KD, Ruzicka M, deChamplain J, Pylypchuk G, Gledhill N, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Touyz RM, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2007 May 15;23(7):539-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk